SCHEMBL166826

SCHEMBL166826

c1ccc2nc3c4cccnc4c4ncccc4c3nc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.54
HSP90AA1 P07900 2/20 0.54
NPC1 O15118 2/20 0.54
CYP3A4 P08684 2/20 0.54
ALDH1A1 P00352 3/20 0.52
LMNA P02545 2/20 0.52
DHFR P00374 1/20 0.50
CCR1 P32246 4/20 0.48
CCR8 P51685 4/20 0.48
KDM4E B2RXH2 4/20 0.48
MAPT P10636 4/20 0.48
TP53 P04637 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CCR5 P51681 2/20 0.48
GMNN O75496 1/20 0.48
MMP2 P08253 1/20 0.48
CYP2D6 P10635 1/20 0.48
MMP9 P14780 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30185055 1.00 L3MBTL1 (0.54) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL30185058 1.00 L3MBTL1 (0.54) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL29390114 1.00 L3MBTL1 (0.54) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL6693951 0.98 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL29833113 0.98 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL5931379 0.98 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL351170 0.96 L3MBTL1 (0.50) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL16635990 0.96 L3MBTL1 (0.50) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL30565589 0.96 L3MBTL1 (0.50) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1
SCHEMBL17274754 0.94 CYP3A4 (0.48) L3MBTL1HSP90AA1NPC1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 893 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263804-A1 METHOD FOR DETECTING A TARGET GENOME Università degli Studi di Messina (IT) 2025-08-21 US claimed
WO-2025132825-A1 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) 2025-06-26 WO claimed
US-20250207181-A1 PROCESS FOR DETECTING A TARGET NUCLEIC ACID ALMA MATER STUDIORUM - Universita' di Bologna (90%) (IT) 2025-06-26 US claimed
US-20250074925-A1 RARE EARTH COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2025-03-06 US claimed
EP-4499863-A1 PROCESS FOR DETECTING A TARGET NUCLEIC ACID Alma Mater Studiorum - Università di Bologna (IT) 2025-02-05 EP claimed
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 EP claimed
WO-2023187605-A1 PROCESS FOR DETECTING A TARGET NUCLEIC ACID Alma Mater Studiorum - Università di Bologna (IT) 2023-10-05 WO claimed
US-20230313033-A1 Nanoparticles To Improve Analytical Signal Alma Mater Studiorum - Università di Bologna (IT) 2023-10-05 US claimed
WO-2023165077-A1 THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL BASED ON DIPYRIDINOPHENAZINE ACCEPTOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州大学 2023-09-07 WO claimed
EP-4211079-A1 NANOPARTICLES TO IMPROVE ANALYTICAL SIGNAL Alma Mater Studiorum Universita di Bologna (IT) 2023-07-19 EP claimed
US-20050112703-A1 Membrane-based lateral flow assay devices that utilize phosphorescent detection KIMBERLY-CLARK WORLDWIDE, INC. 2005-05-26 US claimed
US-20040197801-A1 Nucleic acid sequence detection APPLIED BIOSYSTEMS, INC. 2004-10-07 US claimed
US-20040146895-A1 Luminescent metal ion complexes BIOSEARCH TECHNOLOGIES, INC. 2004-07-29 US claimed
WO-2004037907-A2 LUMINESCENT METAL ION COMPLEXES BIOSEARCH TECHNOLOGIES, INC. (US) 2004-05-06 WO claimed
US-20030198960-A1 Signal amplifying targeted reporters for biological and chemical sensor applications INTEGRATED NANOSYSTEMS, INC. 2003-10-23 US claimed
WO-2000047693-A9 LUMINESCENT METAL-LIGAND COMPLEXES LJL BIOSYSTEMS INC (US) 2002-04-11 WO claimed
US-20010021514-A1 Luminescent metal-ligand complexes LJL BIOSYSTEMS, INC. 2001-09-13 US claimed
WO-2000047693-A1 LUMINESCENT METAL-LIGAND COMPLEXES LJL BIOSYSTEMS, INC. (US) 2000-08-17 WO claimed
US-5942616-A Metal ion coordinated complex crystal KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 1999-08-24 US claimed
US-5157032-A Spectroscopically or photoactively determinable THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1992-10-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040146895-A1 Luminescent metal ion complexes SLC30A6, SLC39A14, SLC39A3 L3MBTL1 753/4885HSP90AA1 2714/4885NPC1 2001/4885
US-20250074925-A1 RARE EARTH COMPLEX L1CAM, CHRM1, NPM1 L3MBTL1 233/4885HSP90AA1 1610/4885NPC1 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.